Analysts have largely kept their calls and target prices unchanged following Mapletree Commercial Trust’s (MCT) 1QFY2021/2022 ended June results, which were released late last week.
See also: Mapletree Commercial Trust posts 23% higher NPI of $96.9 mil for 1QFY21/22
UOB Kay Hian was the sole analyst with an adjustment in target price, revising it downwards to $2.48 from $2.50 previously while keeping its “buy” call.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
